SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-000141
Filing Date
2022-02-14
Accepted
2022-02-14 16:31:24
Documents
60
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q nnvc-20211231x10q.htm   iXBRL 10-Q 1416801
2 EX-31.1 nnvc-20211231xex31d1.htm EX-31.1 12753
3 EX-31.2 nnvc-20211231xex31d2.htm EX-31.2 13685
4 EX-32.1 nnvc-20211231xex32d1.htm EX-32.1 11118
5 EX-32.2 nnvc-20211231xex32d2.htm EX-32.2 11283
  Complete submission text file 0001410578-22-000141.txt   5407836

Data Files

Seq Description Document Type Size
6 EX-101.SCH nnvc-20211231.xsd EX-101.SCH 43674
7 EX-101.CAL nnvc-20211231_cal.xml EX-101.CAL 34077
8 EX-101.DEF nnvc-20211231_def.xml EX-101.DEF 197284
9 EX-101.LAB nnvc-20211231_lab.xml EX-101.LAB 283329
10 EX-101.PRE nnvc-20211231_pre.xml EX-101.PRE 279375
54 EXTRACTED XBRL INSTANCE DOCUMENT nnvc-20211231x10q_htm.xml XML 836447
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

IRS No.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36081 | Film No.: 22632981
SIC: 2834 Pharmaceutical Preparations